Haemonetics Corp (HAE) Actualités

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 144 - Report of proposed sale of securities

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website

Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website PR Newswire BOSTON, Nov. 7, 2024 Financial...

Form 4 - Statement of changes in beneficial ownership of securities

Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2025 Results: November 7, 2024

Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2025 Results: November 7, 2024 PR Newswire BOSTON, Oct. 3, 2024 BOSTON, Oct. 3...

Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer

SOUTH SAN FRANCISCO, Calif., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a...

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System PR Newswire BOSTON, Aug. 15, 2024 BOSTON, Aug. 15, 2024...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]